Education
About Us
Working with TipRanks
Follow Us
Jane Chung Insider Profile
4 Followers
Jane Chung, CEO, Director at Sutro Biopharma, holds 122.85K shares in Sutro Biopharma (Ticker: STRO), holds ― shares in Viracta Therapeutics (Ticker: VIRX). Most recently, Jane Chung Bought ― shares of Sutro Biopharma on Oct 16, 2025 for an estimated value of $10.00K.
Jane Chung has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Jane Chung holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jane Chung
Jane Chung's Trading History
Sutro Biopharma
Oct 16, 2025
CEO, Director
Informative Buy
10.00K
$124.08K
Viracta Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Jane Chung's performance on stock
You May Also Like
Jane Chung insider profile FAQ
What is the percentage of profitable transactions made by Jane Chung?
The percentage of profitable transactions made by Jane Chung is ―.
What is the average return per transaction made by Jane Chung?
The average return per transaction made by Jane Chung is ―.
What stocks does Jane Chung hold?
Jane Chung holds: STRO, VIRX stocks.
What was Jane Chung’s latest transaction?
Jane Chung latest transaction was an Informative Buy of $10.00K.
What was Jane Chung's most profitable transaction?
Jane Chung’s most profitable transaction was an Informative Buy of STRO stock on October 16, 2025. The return on the trade was 14.70%.
What is Jane Chung's role in Sutro Biopharma?
Jane Chung's role in Sutro Biopharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.